DXS InternationalAQSE:DXSP Pretax Margin % is -5.04% as of Apr. 2025. The stock has 2 warning signs investors should review. Among 666 Healthcare Providers & Services companies, DXS International ranks worse than 71.77% on this metric.
The historical rank and industry rank for DXS International's Pretax Margin % or its related term are showing as below:
AQSE:DXSP'
s Pretax Margin % Range Over the Past 10 Years
Min: -149.7 Med: -2.12 Max: 7.29
Current: -5.04
AQSE:DXSP's Pretax Margin % is ranked worse than 71.77% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 4.01
vs AQSE:DXSP: -5.04
DXS International (AQSE:DXSP) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
DXS International Pretax Margin % Related Terms
DXS International Pretax Margin % Historical Data
* Premium members only.
The historical data trend for DXS International's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AQSE:DXSP vs VEEV, BTSG, TEM: Pretax Margin % Comparison
For the Health Information Services subindustry, DXS International's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DXS International Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DXS International's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where DXS International's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DXS International (AQSE:DXSP) has a Pretax Margin % of -5.04% as of Apr. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on DXS International and its competitors. According to the industry distribution chart, DXS International ranks #478 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 71.8%.
Is DXS International's Pretax Margin % too high?
DXS International's current Pretax Margin % is -5.04%. Based on the distribution chart, DXS International ranks #478 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does DXS International's Pretax Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #478 out of 666 companies for Pretax Margin %. This places DXS International in the lower half of its industry. The industry median Pretax Margin % is 4.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.01, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on DXS International and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current Pretax Margin % is -5.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.01 — trading 37.5% below its estimated fair value. The current Pretax Margin % is -5.04%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current Pretax Margin % is -5.04% as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQSE:DXSP has been successfully added to your 